Medifast Q2 revenue up 15% to $453.3M, net income down 16.7%; cuts full-year guidance on macro headwinds

MEDIFAST INC

2022-Q2 EPS reported $7.01 revenue$870,933,000

Revenue $453.3M (+15% YoY); net income $39.1M (-16.7%); adjusted EPS $3.87 (-2.5%).
Active earning coaches 68,000 (+14.9%); revenue per coach $6,667 slightly above prior year.
Gross margin 71.0% vs 74.5% YoY due to customer acquisition costs and higher raw ingredient costs.
Entered $100M accelerated share repurchase; quarterly dividend $1.64/share.
Full-year 2022 guidance lowered: revenue $1.58B-$1.66B (prev. $1.78B-$1.84B); adjusted EPS $12.70-$14.10 (prev. $14.60-$16.05) due to inflation and consumer sentiment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.